Contact this trialFirst, we need to learn more about you.
Colchicine Derivative
CCI-001 for Cancer
Recruiting1 awardPhase 1
Edmonton, Alberta
This trial is testing a new drug, called CCI-001, to see if it is safe for humans and to find the best dose. The drug is designed to attack cancer cells by binding to a protein that is important for cell division. The trial will also look at how well the drug works against different types of cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.